Appeals Court Reverses Insurance-Claim Verdict Favoring Stryker
A three-judge panel in the Sixth Circuit Court of Appeals handed found that TIG Insurance Company does not need to cover Stryker's damages in a patient suit tied to a knee implant that was marketed by the firm.
You may also be interested in...
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.
Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program.
The US agency is relaxing some regulatory requirements on facial masks and actively pursuing ways to reprocess N95 respirators used by medical staff under an immediately-in-effect guidance document.